Compounded GLP-1 RA drugs: GLP-1 RA drugs are no longer in shortage, but compounding customized versions of them may continue, part 1

The U.S. Food and Drug Administration has ruled GLP-1 RA drugs are no longer in shortage. That ruling affects how compounding pharmacists may mix those drugs. Scott Brunner, CAE, CEO of the Alliance for Pharmacy Compounding, explains the rules that compounding pharmacists operate under, especially for the antidiabetes and antiobesity drugs that have exploded in popularity.